Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119234) titled 'A study comparing standard anti-tubercular treatment alone versus standard treatment with intravitreal bevacizumab and moxifloxacin injections for treating intraocular tubercular granulomas' on Oct. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded
Primary Sponsor: Dr Shroff Charity Eye Hospital
Condition:
Health Condition 1: H300- Focal chorioretinal infl...